SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017036
Filing Date
2022-11-09
Accepted
2022-11-09 08:30:54
Documents
60
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20220930x10q.htm   iXBRL 10-Q 1279249
2 EX-10.1 glyc-20220930xex10d1.htm EX-10.1 140076
3 EX-31.1 glyc-20220930xex31d1.htm EX-31.1 16959
4 EX-31.2 glyc-20220930xex31d2.htm EX-31.2 16775
5 EX-32.1 glyc-20220930xex32d1.htm EX-32.1 9438
  Complete submission text file 0001558370-22-017036.txt   5431651

Data Files

Seq Description Document Type Size
6 EX-101.SCH glyc-20220930.xsd EX-101.SCH 34299
7 EX-101.CAL glyc-20220930_cal.xml EX-101.CAL 36028
8 EX-101.DEF glyc-20220930_def.xml EX-101.DEF 158488
9 EX-101.LAB glyc-20220930_lab.xml EX-101.LAB 342461
10 EX-101.PRE glyc-20220930_pre.xml EX-101.PRE 277815
54 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20220930x10q_htm.xml XML 862762
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 221370783
SIC: 2834 Pharmaceutical Preparations